Form 4: Astera Labs CFO Transfers Shares to Tate Trust
SEC Filing
Chief Financial Officer Michael Truett Tate transferred 1,033,780 shares of Astera Labs common stock to the Tate Trust on October 2, 2024.
Summary
- On October 2, 2024, Michael Truett Tate, the Chief Financial Officer of Astera Labs, Inc., transferred 1,033,780 shares of common stock to the Tate 1997 Living Trust.
- The transfer was made for no consideration.
- Following the transaction, Mr. Tate directly owns 293,128 shares of common stock.
- The Tate Trust indirectly owns 1,862,888 shares.
- Mr. Tate disclaims beneficial ownership of the shares held by the Tate Trust, except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding a share transfer. It doesn't convey any positive or negative sentiment about the company's performance or prospects.
Industry Context
This is a routine disclosure of insider transactions and doesn't necessarily reflect a change in the company's outlook or performance.
Stakeholder Impact
- The transfer of shares to a trust has no immediate impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| April 24, 1997 | Date of the Tate 1997 Living Trust |
| October 02, 2024 | Date of the share transfer to the Tate Trust |
| October 04, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.